| Product Name | MF | CAS | Details |
|---|
| Xylose Impurity 17 | C10H13NO3 | 106868-33-1 | Details |
| Bempedoic Acid Impurity 54 | C11H15NO3 | 42832-22-4 | Details |
| Prinomastat Impurity 1 | C9H13N2O9P | 58-97-9 | Details |
| MethotrexateImpurity39 | C7H8N6 | 4215-07-0 | Details |
| ClavulanateLithium | C26H41Br2NO4 | 1970218-70-2 | Details |
| INDEXNAMENOTYETASSIGNED | C6H6D2O4 | 23057-98-9 | Details |
| 2H-1,4-Benzoxazin-3(4H)-one,2-(β-D-glucopyranosyloxy)-4,7-dihydroxy-,(2R)- | C26H31ClN2O4 | 2736513-26-9 | Details |
| 2-(3-Benzoylphenyl)aceticacid | C69H107ClO46S7 | 2379877-88-8 | Details |
| BrexpiprazoleD8 | C17H21BrClNO2 | 2247155-46-8 | Details |
| Methotrexatedisodiumsalt | C17H24N2O5 | 2378-95-2 | Details |
| 7-CyanoDAMPAEthylEster | C7H8N6O | 881-33-4 | Details |
| 7-HydroxyDAMPA | C7H6N6O | 4261-17-0 | Details |
| RYJBXJXLCKKHER-UHFFFAOYSA-N | C7H8N6O2 | 54643-27-5 | Details |
| L-Glutamicacid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-,1-ethylester | C23H28N8O5 | 1233519-38-4 | Details |
| Sarolaner Impurity 21 | 1575794-64-7 | Details |
| Sarolaner Impurity 27 | 1398609-46-5 | Details |
| Sarolaner Impurity 43 | 1575794-68-1 | Details |
| Sarolaner Impurity 48 | 1575836-01-9 | Details |
| Ritlecitinib Impurity 41 | 2411407-22-0 | Details |
| Ritlecitinib Impurity 46 | 2411406-93-2 | Details |
| Ritlecitinib Impurity 61 | 2411407-44-6 | Details |
| Fedratinib Impurity 6 | 1332719-50-2 | Details |
| Ritlecitinib Impurity 44 | 2411407-58-2 | Details |
| Ritlecitinib Impurity 49 | 2411407-65-1 | Details |
| Fedratinib Impurity 4 | 1802659-73-9 | Details |
| 1,5-Naphthyridine,1,5-dioxide | C10H8N2O3 | 4831-62-3 | Details |
| 1,5-Naphthyridine,1-oxide | C9H6ClNO | 4637-59-6 | Details |
| Quinoline,2-chloro-,1-oxide | C10H8ClNO | 41037-32-5 | Details |
| isoquinoline1-carboxylicacidN-oxide | C11H11NO2 | 41037-31-4 | Details |
| Quinoline,8-methoxy-,1-oxide | C10H9NO | 4053-40-1 | Details |
| Isoquinoline,5-bromo-,2-oxide | C10H9NO | 4053-38-7 | Details |
| Quinoline,4-bromo-,1-oxide | C10H9NO | 4053-42-3 | Details |
| Lactic Acid Impurity 52 | C16H19N3O5S | 26787-78-0 | Details |
| Stavudine Impurity 11 | C9H11NO | 620-71-3 | Details |
| Ripretinib Impurity 41 | C27H34N2O5S | 1027854-97-2 | Details |
| 2(1H)-Quinolinone,7-[4-(1-piperazinyl)butoxy]- | 2514958-62-2 | Details |
| (Z)-4-(6-bromo-2-methoxyquinolin-3-yl)-N,N-dimethyl-3-(naphthalen-1-yl)-4-phenylbut-3-en-1-amine | C32H31BrN2O2 | 654653-93-7 | Details |
| 3-Pyridinesulfonamide | C17H17ClFN3O2S | 881681-79-4 | Details |
| (1R,2R)-1-(6-Bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-naphthalen-1-yl-1-phenylbutan-2-ol | C10H8N2O3 | 14094-45-2 | Details |
| Esomeprazole Impurity 58 | C9H12ClNO | 1424857-95-3 | Details |
| amphotericinA | C20H23NO5 | 2733641-85-3 | Details |
| AmlodipineImpurity31 | C22H27ClN2O6 | 93848-82-9 | Details |
| 2H-Pyran,3,4-dihydro-6-methyl- | C5H7N3O2 | 6972-77-6 | Details |
| Minocycline Impurity 7（Minocycline Dehydro Impurity） | C23H25N3O7 | 19119-14-3 | Details |
| (1S,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol | C10H8N2O3 | 14073-00-8 | Details |
| Cefazolin Impurity 2（Cefazolin EP Impurity B）（Cefazolin USP RC N） | C16H20N4O4S3 | 2384108-14-7 | Details |
| (1-hydroxy-5-nitro-8-oxo-8,8a-dihydroquinolinium) | C9H11NO2 | 39585-74-5 | Details |
| 8-Quinolinol,5-chloro-,1-oxide | C10H9NO2 | 39585-73-4 | Details |
| 3-MethylquinolineN-oxide | C11H11NO2 | 361576-36-5 | Details |
| Isoquinoline,3-methyl-,2-oxide | C10H7NO3 | 3297-64-1 | Details |
| Quinoline,4-methoxy-,1-oxide | C9H7NO2 | 3039-74-5 | Details |
| Quinoline,8-methyl-4-nitro-,1-oxide | C8H6N2O2 | 27305-49-3 | Details |
| 3-Methyl-4-nitroquinoline1-oxide | C8H6N2O | 27305-48-2 | Details |
| 4-Methoxy-5,6,7,8-tetrahydroquinoline1-oxide | C9H6ClNO | 2423-68-9 | Details |
| (αR,βS)-rel-Bedaquiline | C10H7NO3 | 22960-55-0 | Details |
| 4-Amino-2-methylnaphthalen-1-olhydrochloride | C9H6BrNO | 22614-98-8 | Details |
| 4-(6-Bromo-2-methoxy-3-quinolinyl)-N,N-dimethyl-3-(1-naphthalenyl)-4-phenyl-2-buten-1-amine | C11H12ClNO | 130-24-5 | Details |
| VonoprazanImpurity1 | C11H7ClN2 | 158692-52-5 | Details |
| Bedaquiline | C10H13NO2 | 125162-99-4 | Details |
| (2R)-1-(6-Bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-naphthalen-1-yl-1-phenylbutan-2-ol | C10H9NO2 | 14547-98-9 | Details |
| Bedaquiline(MixtureofDiastereomers) | C10H9NO | 14548-00-6 | Details |
| Quinoline,2-methoxy-,1-oxide | C9H7NO2 | 188530-04-3 | Details |
| Quinoline,4-ethoxy-6-methyl-,1-oxide | C9H6BrNO | 223671-17-8 | Details |
| 2-MethylquinolineN-oxide | C10H9NO2 | 22614-90-0 | Details |
| (R)-(-)-Ketoprofen | C11H11ClN4O3S | 5018-23-5 | Details |
| rac-2’,4’-DimethylKetoprofen | C14H16N4O5S | 5018-54-2 | Details |
| rac-2’,4’,5’-TrimethylKetoprofen | C11H12N4O4S | 1346604-08-7 | Details |
| Dexketoprofen | C6H9N3O2 | 5018-45-1 | Details |
| 1,1′,3,3′-Tetrahydro[2,2′-bi-2H-indene]-2,2′-diol | C18H18O2 | 93877-16-8 | Details |
| Valerophenone | C15H15N | 1458609-07-8 | Details |
| Zaltoprofen | C9H11NO | 138911-07-6 | Details |
| KetoprofenTromethamineAmide | C12H11NO | 1312077-05-6 | Details |
| Benzeneaceticacid,3-benzoyl-a-methyl-,ethylester | C9H11N | 10277-74-4 | Details |
| org246653-1 | C72H113NaO50S8 | 2412953-09-2 | Details |
| INDEX NAME NOT YET ASSIGNED | C69H109NaO46S8 | 2379877-91-3 | Details |
| Sugammadex Impurity 22 | C72H113NaO48S8 | 2412952-94-2 | Details |
| (S)-(+)-Ibuprofen | C72H113NaO48S9 | 2412952-92-0 | Details |
| Azetidine,1-(6-ethynyl-2,3-dihydro-1H-inden-1-yl)-(9CI) | C14H15N | 371251-20-6 | Details |
| 2,3-dihydro-N1-2-propyn-1-yl-1H-Indene-1,6-diamine | C12H14N2 | 863987-58-0 | Details |
| ExemestaneRelatedCompound3 | C8H18N2O | 108015-71-0 | Details |
| Androsta-1,4-diene-3,17-dione,4-chloro-6-methylene- | C6H15NO2 | 38711-20-5 | Details |
| ExemestaneImpurity13 | C7H5BiO4 | 14882-18-9 | Details |
| Methanone,(3-chloro-1H-indol-7-yl)phenyl- | C17H14O4S | 134085-79-3 | Details |
| 1-(Phenylcarbamoyl)cyclopropanecarboxylicacid | C15H23NO2 | 83394-44-9 | Details |
| Methyl2,3-O-isopropylidene-beta-D-ribofuranoside | C12H14O2 | 103931-20-0 | Details |
| AmphoteronolideB | C10H11NO3 | 1272414-15-9 | Details |
| Benzenesulfonicacid,4-methyl-,(2R)-2-ethylhexylester | C11H14O | 1009-14-9 | Details |
| Sugammadex Impurity 4 | C72H112O48S8 | 343306-71-8 | Details |
| Heptanal,3-hydroxy-2-propyl- | C17H14O3S | 74711-43-6 | Details |
| Meester-(E)-Clavulanicacid,BAN,INN | C23H32N6O6 | 2832083-17-5 | Details |
| 5-O-Phosphono-beta-D-Ribofuranose | C16H16O3 | 59960-32-6 | Details |
| Methyl(2R,3E,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate | C10H9NO2 | 192225-36-8 | Details |
| Benzene,1,4-dichloro-2-(trichloromethyl)- | C10H9NO2 | 5537-71-3 | Details |
| 3-(CYANOMETHYL)BENZOIC ACID | C9H7NO2 | 5689-33-8 | Details |
| Exemestane | C14H17NO4 | 1158699-78-5 | Details |
| Methyleneboldenone | C19H22N2O2 | 1289178-26-2 | Details |
| ExemestaneRelatedCompoundB | C35H43N5O4 | 864750-95-8 | Details |
| Unii-L742P1D49E | C14H9N3O3 | 108335-90-6 | Details |
| Ethanamine,2,2-dimethoxy-N,N-dimethyl- | C10H14N.Cl | 50663-73-5 | Details |
| Benzoic acid, 4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]-, methyl ester | C15H20N2O3 | 733783-20-5 | Details |
| Product Total： Product Page： | ||||
| 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 | ||||